Cargando…
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Oncogenic KRAS is the key driver of pancreatic ductal adenocarcinoma (PDAC). We previously described a role for KRAS in PDAC tumor maintenance through rewiring of cellular metabolism to support proliferation. Understanding the details of this metabolic reprogramming in human PDAC may provide novel t...
Autores principales: | Santana-Codina, Naiara, Roeth, Anjali A., Zhang, Yi, Yang, Annan, Mashadova, Oksana, Asara, John M., Wang, Xiaoxu, Bronson, Roderick T., Lyssiotis, Costas A., Ying, Haoqiang, Kimmelman, Alec C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251888/ https://www.ncbi.nlm.nih.gov/pubmed/30470748 http://dx.doi.org/10.1038/s41467-018-07472-8 |
Ejemplares similares
-
Pancreatic cancers depend on a non-canonical glutamine metabolism pathway
por: Lyssiotis, Costas, et al.
Publicado: (2014) -
Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway
por: Son, Jaekyoung, et al.
Publicado: (2013) -
Pancreatic cancers rely on a novel glutamine metabolism pathway to maintain redox balance
por: Lyssiotis, Costas A., et al.
Publicado: (2013) -
USP21 deubiquitinase elevates macropinocytosis to enable oncogenic KRAS bypass in pancreatic cancer
por: Hou, Pingping, et al.
Publicado: (2021) -
Oncogenic KRAS signalling in pancreatic cancer
por: Eser, S, et al.
Publicado: (2014)